Abstract
We performed a meta-analysis to comprehensively investigate the efficacy and safety of immune-checkpoint inhibitors (ICIs) plus chemotherapy in patients with extensive-stage small cell lung cancer (ES-SCLC). The primary outcome was...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have